Top

CardioVascular and Interventional Radiology

Published in:

01-10-2013 | Review/State of the Art

Acute Cor Pulmonale and Right Heat Failure Complicating Ethanol Ablative Therapy: Anesthetic and Radiologic Considerations and Management

Authors: Bhiken Naik, Alan H. Matsumoto

Published in: CardioVascular and Interventional Radiology | Issue 5/2013

Abstract

Ethanol is an effective ablative agent used for the treatment of certain solid organ tumors and vascular malformations (VMs). The egress of ethanol beyond the target tissue can be associated with significant changes to the cardiopulmonary system that can lead to cardiac arrest. This article reviews the contemporary role of ethanol in tumor and VM treatment and discusses the physiological mechanisms of acute pulmonary hypertension and cardiovascular collapse. The importance of periprocedural recognition of the hemodynamic changes that can occur with the use of ethanol and the treatment of this condition are discussed.

Livraghi T, Lazzaroni S, Pellicano S et al (1993) Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia. AJR Am J Roentgenol 161:1065–1069CrossRefPubMed

Yakes WF, Rossi P, Odink H (1996) How I do it. Arteriovenous malformation management. Cardiovasc Interv Radiol 19:65–71CrossRef

Naik B, Lobato E, Urdaneta F (2004) Acute cardiovascular instability during percutaneous ethanol injection of a hepatocellular carcinoma under general anesthesia. Anesthesiology 100:1307–1308CrossRefPubMed

Garel L, Mareschal JL, Gagnadoux MF et al (1986) Fatal outcome after ethanol renal ablation in child with end-stage kidneys. AJR Am J Roentgenol 146:593–594CrossRefPubMed

Buchta K, Sands J, Rosenkrantz H et al (1982) Early mechanism of action of arterially infused alcohol USP in renal devitalization. Radiology 145:45–48PubMed

Ellman BA, Parkhill BJ, Marcus PB et al (1984) Renal ablation with absolute ethanol. Mechanism of action. Investig Radiol 19:416–423CrossRef

Alam M, Dokainish H, Lakkis N (2006) Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 19:319–327CrossRefPubMed

McWilliams JP, Yamamoto S, Raman SS et al (2010) Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol 21:S204–S213CrossRefPubMed

Livraghi T, Benedini V, Lazzaroni S et al (1998) Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83:48–57CrossRefPubMed

10.

Lencioni R, Bartolozzi C, Caramella D et al (1995) Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 76:1737–1746CrossRefPubMed

11.

Shiina S, Tagawa K, Niwa Y et al (1993) Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 160:1023–1028CrossRefPubMed

12.

Livraghi T, Bolondi L, Buscarini L et al (1995) No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol 22:522–526CrossRefPubMed

13.

Behnia R (1995) Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg 80:415–417PubMed

14.

Do YS, Yakes WF, Shin SW et al (2005) Ethanol embolization of arteriovenous malformations: interim results. Radiology 235:674–682CrossRefPubMed

15.

Cantasdemir M, Gulsen F, Solak S et al (2012) The use of Onyx for embolization of peripheral vascular malformations in pediatric patients. Pediatr Surg Int 28:477–487CrossRefPubMed

16.

Hammer FD, Boon LM, Mathurin P et al (2001) Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol 12:595–600CrossRefPubMed

17.

Lee JJ, Do YS, Kim JA (2004) Serum ethanol levels after alcohol sclerotherapy of arteriovenous malformations. J Korean Med Sci 19:51–54CrossRefPubMed

18.

Nimmaanrat S, Prechawai C, Tanomkiat W (2007) Anesthetic techniques and complications in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection. Minerva Anestesiol 73:333–337PubMed

19.

Chapot R, Laurent A, Enjolras O et al (2002) Fatal cardiovascular collapse during ethanol sclerotherapy of a venous malformation. Interv Neuroradiol 8:321–324PubMed

20.

Sidi A, Naik B, Muehlschlegel JD et al (2008) Ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs. Br J Anaesth 100:568–569CrossRefPubMed

21.

Shin BS, Do YS, Cho HS et al (2010) Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. J Vasc Interv Radiol 21:81–89CrossRefPubMed

22.

Shin BS, Do YS, Lee BB et al (2005) Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology 235:1072–1077CrossRefPubMed

23.

Rother RP, Bell L, Hillmen P et al (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653–1662CrossRefPubMed

24.

Kielstein JT, Hesse G, Bahr MJ et al (2009) Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection—role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med 37:1483–1485CrossRefPubMed

25.

Mottu F, Stelling MJ, Rufenacht DA et al (2001) Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection. PDA J Pharm Sci Technol 55:16–23PubMed

26.

Schwesinger WH, Kurtin WE (1984) Effects of ethanol infusion on serum hemoglobin and bile pigments. J Surg Res 37:43–47CrossRefPubMed

27.

Villagra J, Shiva S, Hunter LA et al (2007) Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110:2166–2172CrossRefPubMed

28.

Barnett CF, Hsue PY, Machado RF (2008) Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. JAMA 299:324–331CrossRefPubMed

29.

Kielstein JT, Bode-Boger SM, Hesse G et al (2005) Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 25:1414–1418CrossRefPubMed

30.

Kielstein JT, Fliser D, Veldink H (2009) Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 22:346–350CrossRefPubMed

31.

Child JS, Kovick RB, Levisman JA et al (1979) Cardiac effects of acute ethanol ingestion unmasked by autonomic blockade. Circulation 59:120–125CrossRefPubMed

32.

Kettunen R, Timisjarvi J, Saukko P (1992) The acute dose-related effects of ethanol on right ventricular function in anesthetized dogs. Alcohol 9:149–153CrossRefPubMed

33.

Guarnieri T, Lakatta EG (1990) Mechanism of myocardial contractile depression by clinical concentrations of ethanol. A study in ferret papillary muscles. J Clin Investig 85:1462–1467CrossRefPubMed

34.

Thomas AP, Sass EJ, Tun-Kirchmann TT et al (1989) Ethanol inhibits electrically-induced calcium transients in isolated rat cardiac myocytes. J Mol Cell Cardiol 21:555–565CrossRefPubMed

35.

Ma H, Yu L, Byra EA et al (2010) Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases. J Mol Cell Cardiol 49:322–329CrossRefPubMed

36.

Pritts CD, Pearl RG (2010) Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol 23:411–416CrossRefPubMed

37.

Ko JS, Kim CS, Shin BS et al (2011) Changes in pulmonary artery pressures during ethanol sclerotherapy for arteriovenous malformations: identifying the most vulnerable period. Clin Radiol 66:639–644CrossRefPubMed

38.

Prielipp RC, Rosenthal MH, Pearl RG (1988) Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep. Anesthesiology 68:552–558CrossRefPubMed

39.

Sidi A, Naik B, Urdaneta F et al (2008) Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs, by sildenafil analogue (UK343–664) or nitroglycerin. Ann Cardiac Anaesth 11:97–104CrossRef

40.

Kim JS, Nam MH, Do YS et al (2010) Efficacy of milrinone versus nitroglycerin in controlling pulmonary arterial hypertension induced by intravenous injections of absolute ethanol in anesthetized dogs. J Vasc Interv Radiol 21:882–887CrossRefPubMed

41.

Muehlschlegel JD, Lobato EB, Kirby DS et al (2007) Inhaled amyl nitrite effectively reverses acute catastrophic thromboxane-mediated pulmonary hypertension in pigs. Ann Card Anaesth 10:113–120CrossRefPubMed

42.

Winterhalter M, Antoniou T, Loukanov T (2010) Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options. Cardiology 116:3–9CrossRefPubMed

43.

Vlahakes GJ, Turley K, Hoffman JI (1981) The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63:87–95CrossRefPubMed

44.

Rieg AD, Rossaint R, Uhlig S et al (2011) Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices. PLoS ONE 6:e29698CrossRefPubMed

Title: Acute Cor Pulmonale and Right Heat Failure Complicating Ethanol Ablative Therapy: Anesthetic and Radiologic Considerations and Management
Authors: Bhiken Naik
Alan H. Matsumoto
Publication date: 01-10-2013
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 5/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-013-0549-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Acute Cor Pulmonale and Right Heat Failure Complicating Ethanol Ablative Therapy: Anesthetic and Radiologic Considerations and Management

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Safety of Repeated Yttrium-90 Radioembolization

Treatment of Visceral Aneurysm Using Multilayer Stent: Two-Year Follow-Up Results in Five Consecutive Patients

The Role of Postintervention Pullback Pressure Gradient in Percutaneous Transluminal Angioplasty for Central Vein Stenosis in Dialysis Patients

Alternative Treatment for Bleeding Peristomal Varices: Percutaneous Parastomal Embolization

MR-Guided High-Intensity Focused Ultrasound: Current Status of an Emerging Technology

Rare Anomalous Origin of Superior Left Pulmonary Artery from Left Subclavian Vein